Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06613256 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Characterisation of Endothelial Cells in Different Inflammatory Pathologies

Study acronym: JEDI-2
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 25, 2024 (before its estimated July 17, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The goal of this observational study is to characterise changes in gene expression in endothelial cells in patients with either sepsis or post major abdominal surgery. The main question we plan to answer is: 'What molecular pathways are differentially expressed during inflammatory pathologies?'
Trial Details
NCT Number NCT06613256
Lead Sponsor Royal Surrey County Hospital NHS Foundation Trust
Collaborators: University of Surrey
Conditions
(from sponsor)		 Sepsis, Vasoplegia
Related terms Sepsis, Vasoplegia
Enrollment 105 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov